Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000156920 | SCV000206641 | likely benign | not specified | 2014-12-11 | criteria provided, single submitter | clinical testing | p.Ala1191Ala in exon 26 of MYH6: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 0.1% (53/49738) o f European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.br oadinstitute.org). |
Ambry Genetics | RCV000249483 | SCV000320307 | likely benign | Cardiovascular phenotype | 2015-11-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000466529 | SCV000557897 | benign | Hypertrophic cardiomyopathy 14 | 2024-12-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000156920 | SCV000731194 | likely benign | not specified | 2017-06-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
CHEO Genetics Diagnostic Laboratory, |
RCV000769416 | SCV000900809 | benign | Cardiomyopathy | 2017-10-23 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001311848 | SCV001502185 | likely benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | MYH6: BP4, BP7 |
ARUP Laboratories, |
RCV001311848 | SCV004563034 | likely benign | not provided | 2023-10-13 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000156920 | SCV005039610 | benign | not specified | 2024-03-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001311848 | SCV005211374 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000156920 | SCV001919110 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001311848 | SCV001929918 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001311848 | SCV001974334 | likely benign | not provided | no assertion criteria provided | clinical testing |